Bigul

Veerhealth Care Limited - 511523 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayVeerhealth Care Limited 2CINL65910MH1992PLC067632 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: RONY SHAH Designation: COMPANY SECRETARY EmailId: cs@veerhealthcare.net Name of the Chief Financial Officer: AKASH SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: akash@veerhealthcare.net Date: 17/06/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
17-06-2020
Bigul

Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 (LODR) - Disclosure Of Material Impact Of COVID-19 Pandemic

Dear Sir, Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, please find enclosed herewith the disclosure of material impact of COVID-19 pandemic on the operations and performance of the Company. Kindly take the same on your record.
27-05-2020
Bigul

Veerhealth Care Limited - 511523 - Compliances

Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by M/s. Nidhi Shah & Associates, Practicing Company Secretary, for the half year ended March 31, 2020.
26-05-2020
Bigul

Veerhealth Care Limited - 511523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir, Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd., the Registrar and Share Transfer Agent of the Company, for the quarter ended 31st March, 2020.
25-05-2020
Bigul

Veerhealth Care Limited - 511523 - Compliances-Compliance Certificate For The Period March 31, 2020

Dear Sir, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate, duly signed by Share Transfer Agent and the Compliance Officer of the Company for the half year ended March 31, 2020 in compliance of Regulation 7(2) of SEBI Listing Regulations, 2015.
25-05-2020
Bigul

Veerhealth Care Limited - 511523 - Shareholding for the Period Ended March 31, 2020

Veerhealth Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
14-05-2020
Bigul

Veerhealth Care Limited - 511523 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bhavin S ShahDesignation :- Managing Director / Whole Time Director
14-05-2020
Bigul

Veerhealth Care Limited - 511523 - Results-Financial Results For December 31, 2019

Dear Sir, Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Statement showing the Unaudited Financial Results for the quarter ended December 31, 2019. 2. Limited Review Report on the Unaudited Financial Results for the quarter ended December 31, 2019.
12-02-2020
Bigul

Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting

Dear Sir, This is to inform you that the Board of Directors of the Company at its meeting held today i.e. 12th February, 2020, has inter alia, approved the Unaudited financial results for the quarter ended 31st December, 2019. The Board Meeting commenced at 5.00 p.m. and concluded at 5.50 p.m.
12-02-2020
Bigul

Veerhealth Care Ltd - 511523 - Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 31St December, 2019.

Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve 1. Unaudited financial results of the Company for the quarter ended 31st December, 2019. 2. Any other business with permission of the Chair. Further to our intimation to the Stock Exchange vide our letter dated December 23, 2019 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of the Company which was closed from January 01, 2020 will be opened on February 15, 2020 as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015.
04-02-2020
Next Page
Close

Let's Open Free Demat Account